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Organs-at-riska b s t r a c t
Background and purpose: Target volumes and organs-at-risk (OARs) for radiotherapy (RT) planning are
manually deﬁned, which is a tedious and inaccurate process. We sought to assess the feasibility, time
reduction, and acceptability of an atlas-based autosegmentation (AS) compared to manual segmentation
(MS) of OARs.
Materials and methods: A commercial platform generated 16 OARs. Resident physicians were randomly
assigned to modify AS OAR (AS + R) or to draw MS OAR followed by attending physician correction. Dice
similarity coefﬁcient (DSC) was used to measure overlap between groups compared with attending
approved OARs (DSC = 1 means perfect overlap). 40 cases were segmented.
Results: Mean ± SD segmentation time in the AS + R group was 19.7 ± 8.0 min, compared to 28.5 ± 8.0 min
in the MS cohort, amounting to a 30.9% time reduction (Wilcoxon p < 0.01). For each OAR, AS DSC was
statistically different from both AS + R and MS ROIs (all Steel–Dwass p < 0.01) except the spinal cord
and the mandible, suggesting oversight of AS/MS processes is required; AS + R and MS DSCs were non-dif-
ferent. AS compared to attending approved OAR DSCs varied considerably, with a chiasm mean ± SD DSC
of 0.37 ± 0.32 and brainstem of 0.97 ± 0.03.
Conclusions: Autosegmentation provides a time savings in head and neck regions of interest generation.
However, attending physician approval remains vital.
 2014 Elsevier Ireland Ltd. Radiotherapy and Oncology 112 (2014) 321–325 This is an open access article
under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).The advent of conformal radiotherapy (RT), as well as the devel-
oping paradigm of image-guided RT, affords delivery of tumoricidal
radiation doses to user-deﬁned target volumes while minimizing
dose to organs-at-risk (OARs). However, since the optimization
software responsible for dose-reduction to OARs requires accurate
region of interest (ROI) segmentation for all subsequent dose cal-
culations, accurate ROI deﬁnition is recognized as of paramount
importance for RT planning, representing perhaps contributing to
the most uncertainty in RT planning.
Target volumes and OARs for RT planning are typically manually
deﬁned by human users, which is a tedious and time consumingprocess [1]. Manual segmentation (MS), which uses a digital paint-
brush controlled by the user to outline the ROI, remains highly var-
iable, particularly for novices [2]. Inexperienced trainees or those
who treat particular oncologic sites infrequently may under or
over-contour particular OAR regions-of-interest (ROIs), especially
those that are difﬁcult to visualize on computed tomography (CT).
Atlas-based autosegmentation (AS) algorithms have been shown
to accurately delineate OARs ROIs for a variety of disease sites
and early results show a time saving advantage [3–10].
Head and neck cancers present a unique set of challenges in
terms of target delineation for conformal RT [11,12]. With data
from Fuller et al. suggesting that head and neck cancer target vol-
umes [13] are comparatively difﬁcult to contour, time-consuming,
and have higher inter-observer variability than other anatomic
sites, we sought to ascertain whether time-savings might be
achieved using OAR AS as part of our clinical workﬂow. To this
end we constructed a randomized, blinded prospective in silico
study with the following speciﬁc aims:
322 Auto-segmentation in organs at risk for head and neck radiation therapy(1) Determine the real-time workﬂow feasibility and capacity
for delineation time-reduction using AS software for head
and neck OARs in a representative clinical population.
(2) Evaluate individual OAR acceptability of AS/AS-assisted def-
inition of head and neck ROIs using resident and expert phy-
sician comparators.
Materials and methods
This prospective, randomized, double-blind study was approved
by the Institutional Review Board. Patients being simulated for
deﬁnitive RT ± chemo for head and neck malignancies were
included. Patients were excluded for the following reasons: (1)
under the age of 18 years, (2) prior history of RT or surgery to
the head and neck, and (3) cutaneous malignancies. These patients
were excluded so as to reduce bias as these patients could have
anatomical variations. Patients were simulated supine with chins
extended utilizing a custom thermoplastic mask for immobiliza-
tion. Non-contrast axial CT slices were obtained using 2.5–
3.0 mm slices. All patients were treated using intensity modulated
RT (IMRT) with either the whole-ﬁeld IMRT technique or the half-
beam technique with the upper IMRT ﬁeld matched to a static low
neck ﬁeld as previously described [14].Study design
Following CT acquisition, all DICOM ﬁles were processed using a
commercial, proprietary AS platform (Pinnacle 9.4, SPICE AS algo-
rithm, Philips Healthcare, Andover, MA, USA). This software pack-
age performs an initial registration, dense deformable
registration and then probabilistic reﬁnement using an automated
platform in the background while the user performs other tasks.
Residents were randomly assigned to manually modify AS OARs
ROIs (AS + R) or to draw MS OARs ROIs de novo using a pairwise
randomization technique so that each resident did equal number
of AS + R and MS cases. These 16 OARs included the spinal cord,
brainstem, optic chiasm, mandible, oral cavity, soft palate, larynx,
pharyngeal constrictors as well as bilateral optic nerves, parotid
glands, submandibular glands and cochlea. For the purposes of this
study we did not evaluate gross or clinical tumor volumes as these
display signiﬁcant variation between patients based on clinical
presentation necessitating MS followed by multi-physician exami-
nation and real-time ROI quality assurance, using a methodology
described previously [12,15]. Total resident segmentation/correc-
tion time was recorded. Residents rotate through the head and
neck service during the ﬁrst, second and in either their third or
fourth year of training. Attending physicians subsequently
reviewed all OARs and manually corrected them as necessary,
blinded to AS or MS ROIs priors. All OARs underwent established
processes including approval by the attending physician and the
head and neck service quality assurance team consisting of multi-
ple attending physicians to minimize inter-observer variation in
OAR delineation [12,15]. ROIs were never used for treatment plan-
ning without attending approval.Endpoints and analysis
Speciﬁed outcome variables included overall segmentation time
(including AS processing time) and segmentation accuracy (using
attending physician approved contours as a reference). For this
study, nonparametric statistical comparison was implemented
using the paired Wilcoxon rank sum test for between-group com-
parison of ordinal and scalar variables (Supplement 1). Based on
these calculations, a maximal enrollment of 106 patients (53 per
arm) was approved by the institutional review board, with an
interim analysis conducted when enrollment met 40 patients. Asthe Wilcoxon rank-sum test reached statistical signiﬁcance, enroll-
ment was stopped early as per protocol speciﬁcations.
For ROI accuracy assessment, Dice similarity coefﬁcient (DSC)
was used to measure overlap between the AS, AS with resident cor-
rection (AS + R), and MS compared with attending approved ROIs,
where DSC = 1 means perfect ROI overlap, and DSC = 0 is totally
discordant. An informal a priori threshold DSC of P0.85 was uti-
lized as an acceptability threshold (e.g., ROIs with 85% DSC agree-
ment were considered to require clinically acceptable
modiﬁcation, whereas >15% disagreement was considered
clinically unacceptable within our current workﬂow). A paired
Kruskal–Wallis test was performed using the Steel–Dwass meth-
odology (the non-parametric analog comparable to Tukey’s range
test) was used to compare the total process time between the
groups stratiﬁed by OAR ROI. Univariate descriptive statistics
among the groups were compared using a Pearson v2 test. A
non-Bonferroni-corrected alpha of 0.05 was speciﬁed for statistical
signiﬁcance for all analyses. Data analysis was performed using
Stata/SE 12.0 (Stata Corporation, College Station, TX, USA) and
JMP v10/SAS v9.2 (both by SAS Institute, Cary, NC, USA) statistical
software.Results
Baseline demographic and tumor characteristics were similar
between the 40 cases undergoing MS and AS (Supplemental
Table 1). The median age was 59.8 with a mean body mass index
(BMI) of 29.2. The oropharynx was the most common site of dis-
ease (65.0%), followed by larynx (12.5%) with a range of TNM
stages (Table 1).
All 40 cases were segmented by one of 8 residents and approved
by one of 7 head and neck section expert attending physicians.
Mean ± standard deviation (SD) resident segmentation time in
the AS + R group was 19.7 ± 8.0 min, compared to 28.5 ± 8.0 min
in the MS cohort, amounting to a 30.9% time reduction (Wilcoxon
p = 0.002) (Table 1). There was no difference in the number of cases
done by residents in each year of training (p = n.s.). Average time
savings per resident ranged from 2.3–15.7 min.
Fig. 1 displays an example of the AS and attending physician
approved OAR ROIs. The mean ± SD DSC for the uncorrected AS,
AS + R, and MS ROIs compared to ﬁnal attending approved ROIs
was 0.74 ± 0.29, 0.96 ± 0.10, and 0.95 ± 0.16, respectively (Table 2,
Fig. 2). For each OAR, AS DSC was statistically different from both
AS + R and MS ROIs (all Steel–Dwass p < 0.01) except the spinal
cord (p = 0.4) and the mandible (0.4); AS + R and MS DSCs were
non-different (all p = n.s.) suggesting signiﬁcant oversight of AS/
MS processes is still required.
AS accuracy compared to attending approved OAR DSCs varied
considerably with the following structures showing the most over-
lap (i.e., most accurate): mandible (DSC 0.98 ± 0.2), brainstem
(0.97 ± 0.03), pharyngeal constrictors (0.93 ± 0.09), spinal cord
(0.90 ± 0.14), parotid glands (0.89 ± 0.11), and soft palate
(0.86 ± 0.15). However, speciﬁc structures showed reduced DSC
values, representative of poor agreement with expert ROIs. Nota-
bly, the optic chiasm (0.37 ± 0.32), oral cavity (0.53 ± 0.24), cochlea
(0.56 ± 0.38), larynx (0.65 ± 0.26), optic nerves (0.71 ± 0.26), and
submandibular glands (0.73 ± 0.25) were notable for compara-
tively suboptimal segmentation, with a statistically different
performance across OAR ROIs (Steel–Dwass p < 0.01).Discussion
These data represent, to our knowledge, the largest prospective
randomized controlled study evaluating the ROI accuracy and
time-efﬁciency gains of OAR AS software in head and neck RT.
Table 1
Average segmentation time by resident stratiﬁed by randomization to atlas-based autosegmentation or manual segmentation (n = 40).
Number of cases Resident year AS group MS group Difference (min) p
Average (min) Average (min)
Resident 1 6 1 32.7 35.0 2.3
Resident 2 6 1 19.7 35.3 15.7
Resident 3 12 2 15.4 25.3 9.9
Resident 4 4 2 22.0 37.3 15.3
Resident 5 6 3 or 4 20.3 22.5 2.2
Resident 6 2 3 or 4 16.1 22.0 5.9
Resident 7 2 3 or 4 15.4 18.6 3.2
Resident 8 2 3 or 4 8.0 20.0 12.0
Average 40 19.7 28.5 8.8 0.002
SD 8.0 8.0
Abbreviations: AS, atlas-based autosegmentation; MS, manual segmentation; CI, conﬁdence interval.
Fig. 1. Illustrative example of the AS and attending physician approved OAR ROIs.
Table 2
Mean dice similarity coefﬁcient (DSC) values by organ-at risk compared to attending
approved structures.
DSC ± standard deviation*
AS AS + R MS
Brainstem 0.97 ± 0.03 0.99 ± 0.01 0.95 ± 0.14
Spinal cord 0.90 ± 0.14 0.97 ± 0.06 0.90 ± 0.18
Optic nerves 0.71 ± 0.26 0.77 ± 0.24 0.77 ± 0.24
Optic chiasm 0.37 ± 0.32 0.93 ± 0.17 0.96 ± 0.14
Mandible 0.98 ± 0.2 0.99 ± 0.01 0.98 ± 0.05
Parotid glands 0.89 ± 0.11 0.90 ± 0.11 0.90 ± 0.11
Submandibular glands 0.73 ± 0.25 0.76 ± 0.26 0.77 ± 0.26
Oral cavity 0.53 ± 0.24 0.87 ± 0.24 0.92 ± 0.18
Soft palate 0.86 ± 0.15 0.96 ± 0.08 0.93 ± 0.14
Cochleas 0.56 ± 0.38 0.61 ± 0.39 0.60 ± 0.40
Larynx 0.65 ± 0.26 0.94 ± 0.13 0.94 ± 0.15
Pharyngeal constrictors 0.93 ± 0.09 0.98 ± 0.04 0.91 ± 0.17
Abbreviations: AS = uncorrected autosegmented (AS) regions of interest (ROIs),
AS + R = resident corrected AS ROIs, MS = manually segmented (ROIs).
* Dice similarity coefﬁcient (DSC) compared to attending approved.
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neck over manual OARs delineation. AS algorithm-generated struc-
tures were similar to resident MS for several structures. However,
attending physician approval for all OARs remains vital in order to
assure proper normal tissue avoidance during the treatment
planning process, as AS performed poorly for other OAR ROIs.
The goals of AS are to reduce segmentation time, enhance the
accuracy of segmentation, as well as reduce inter- and intra-user
variability [4,11]. These advantages will be essential as the ﬁeld
moves toward increased adoption of adaptive RT,which allows radi-
ation plans to be adapted during the course of treatment based on
clinical and radiographic tumor response and may result in better
normal tissue sparing over the course of treatment and less toxicity
[16]. Initial studies have validated the utility AS for OAR identiﬁca-
tion in adaptive planning of head and neck [17] and prostate cases
[18]. Additionally, with thewidespread adoption of IMRT, clinicians
have to consider toxicities to structures not previously appreciated
with 3D-conformal techniques [19]. Accurately segmenting these
OARROIs is critical in order to adequately spare them. There has also
been shown to be signiﬁcant variability between clinicians in con-
touring target volumes and OARs, which makes RT planning using
uniform normal tissue dose constraints more challenging [20].
Fig. 2. Graphical presentation of Dice similarity coefﬁcient (DSC) values by organ-at risk compared to attending approved structures.
324 Auto-segmentation in organs at risk for head and neck radiation therapyBefore implementing commercial AS tools, potential relative
time savings and software accuracy need to be rigorously investi-
gated, as plan optimization (and thus OAR sparing and target cov-
erage) is predicated on accurate ROI segmentation [21,22]. AS
algorithms have been shown to be quite reliable in appropriately
delineating OARs [5]. Teguh et al. compared MS OARs and target
volumes to AS structures using a commercial atlas-based AS soft-
ware [8]. An expert panel subjectively scored all OARs in the 12
patients as, ‘‘minor deviation, editable’’ or better with excellent
agreement based on DSC. They found AS decreased the total seg-
mentation time of 20 OARs and neck levels from 180 min to
73 min in head and neck cases. Similarly, La Macchia et al. evalu-
ated three commercially available AS tools to determine their clin-
ical utility in delineating OARs in the head and neck, pelvis and
thorax. They concluded that there was signiﬁcant time savings
with AS (approximately 60 min for head and neck cases) [3]. They
found better DSC using MIM 5.1.1, (MIMVista corp, Cleveland,
Ohio) compared to ABAS 2.0 (CMS-Elekta, Stockholm, Sweden) or
VelocityAI 2.6.2 (Velocity Medical Systems, Atlanta, Georgia).
While AS algorithms are promising for workﬂow efﬁciency
improvement, attending physician oversight remains critical. As
Voet et al. conducted an analysis using AS to deﬁne nodal target
volumes as well as OARs which were then used unedited for plan-
ning [23], resulting in under dosage of target volumes, we are as
yet conceptually unwilling to accept unmodiﬁed AS-deﬁned GTV/
CTV ROIs, including elective neck contours generated as AS-con-
toured nodal basins. Our data suggest clinically unacceptable AS
segmentation for several critical OAR structures (e.g., chiasm,
cochlea, and larynx), inadvertent overdosage of which might result
in blindness [24], hearing loss [25], or aspiration/dysphagia [26].
Additionally, it must be carefully stressed that the criticality of
ROI segmentation remains, at its most fundamental, the primary
driver of subsequent planning. For instance, in Fig. 1, a pathologic
lymph node in level II was segmented erroneously as part of the
adjacent submandibular gland. Had this not been detected and
addressed, planning constraints might have been compromised.
For this reason, even as AS serves to augment physician efﬁcacy
in a useful and demonstrable manner, continued clinical vigilance
in CTV and OAR delineation remains imperative in order to ensure
patient safety.
While randomization accounts for much variance, there remain
notable limitations to the present data. The conclusions drawnfrom this study apply only to the speciﬁc version of the AS algo-
rithm used in a head and neck clinic, and must be replicated for
other software systems/versions in other anatomic sites. In addi-
tion, these results only apply to patients being treated with deﬁn-
itive intent, and not patients being treated with post-operative RT.
Competing commercial or research algorithms could have mark-
edly different results in regard to time-savings and/or acceptable
ROI segmentation accuracy. However, we anticipate that these
results would be similar using other algorithms and in other clin-
ical settings. In many departments, OAR ROI generation is done
by technicians, dosimetrists or trainees, which are then reviewed
by attending physicians. We would anticipate similar time savings
in these clinical situations. While one resident segmented a large
number of cases, excluding this individual did not alter the signif-
icant time savings (p = 0.02). In addition, observer bias could alter
efﬁciency estimates, as, while attending physicians were blinded to
AS vs. MS priors, residents were necessarily alerted to the presence
of existing AS structure sets. We chose the DICE index as it assigns
double value to the overlap area, thus reducing the inﬂuence of one
outlier value [7]. It is important to note that this can provide a false
impression of high agreement.
In summary, atlas-based AS priors provided a detectable physi-
cian time savings in head and neck OAR ROI generation over MS,
performing comparably to resident MS for many structures. How-
ever, attending physician approval for all OARs remains vital, as
several key structures including the optic chiasm and optic nerves
were poorly segmented by the AS algorithm. Future studies are
warranted to compare various AS platforms head-to-head.
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